Results 171 to 180 of about 25,218 (212)

Epidemiological features of the 2024 pertussis outbreak in Gyeonggi Province, Korea. [PDF]

Epidemiol Health
Chang YH, Chang K, Ju YJ.
europepmc   +1 more source

Genomic insights into Bordetella pertussis evolution and macrolide resistance in Yiwu, China. [PDF]

BMC Genomics
Xu W, Wei Q, Wu B, Zhu Z, Guan W, Chen G, Xu Z.   +6 more
europepmc   +1 more source

Analysis of Macrolide Resistance in Bordetella pertussis Isolated from Japanese Children in 2025 Using Test Kit and Sequence Method. [PDF]

Biomedicines
Oishi T, Nakano T.
europepmc   +1 more source

Absence of Macrolide-Resistant Mutations in <i>Bordetella pertussis</i> in Antananarivo (Madagascar) and Cambodia During the Last Pertussis Cycle Before the COVID-19 Pandemic. [PDF]

Open Forum Infect Dis
Campana F, Rajabizadeh M, Hide M, Delvallez G, Han S, Rafetrarivony L, Dim B, Harimanana A, Noel G, Ait-Ahmed M, Collard JM, Borand L, Guiso N, Taieb F.   +13 more
europepmc   +1 more source

Modelling pertussis in thailand's southernmost provinces. [PDF]

BMC Public Health
Suwanro S, Wisetsathon B, Ammatawiyanon L, Tongkumchum P.   +3 more
europepmc   +1 more source

Pertussis in Bulgaria, 1952-2001: 50 years of surveillance.

Releve epidemiologique hebdomadaire, 2005
openaire   +1 more source

Surveillance der Effektivität der Pertussis-Impfung: Verwendung von

, 2017
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Surveillance of pertussis: methods and implementation

Expert Review of Anti-infective Therapy, 2016
Pertussis or whooping cough is a respiratory disease caused by Bordetella pertussis or, to a lesser extent, by B. parapertussis. Vaccines against pertussis have been widely used for more than 50 years and have led to a significant reduction of morbidity and mortality.
Nicole, Guiso, Carl Heinz, Wirsing von König   +1 more
openaire   +4 more sources

Comparison of pertussis surveillance systems in Europe

Vaccine, 2007
We compared pertussis surveillance systems of 16 European countries in the period 1998-2002. In twelve out of sixteen countries the system covered the general population. Ten countries relied on WHO case definition for surveillance of pertussis. Eleven countries applied laboratory tests, and eight of them used PCR for case confirmation.
Alberto E, Tozzi, Elisabetta, Pandolfi, Lucia Pastore, Celentano, Marco, Massari, Stefania, Salmaso, Marta L, Ciofi degli Atti   +5 more
openaire   +2 more sources